473 related articles for article (PubMed ID: 34572737)
1. NF-κB and Pancreatic Cancer; Chapter and Verse.
Silke J; O'Reilly LA
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572737
[TBL] [Abstract][Full Text] [Related]
2. NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB.
Kabacaoglu D; Ruess DA; Ai J; Algül H
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277415
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer.
Khurana N; Dodhiawala PB; Bulle A; Lim KH
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32961746
[TBL] [Abstract][Full Text] [Related]
4. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer.
Pramanik KC; Makena MR; Bhowmick K; Pandey MK
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563089
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
6. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
7. HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway.
Li J; Chang J; Wang J; Xu D; Yang M; Jiang Y; Zhang J; Jiang X; Sun Y
Carcinogenesis; 2022 Sep; 43(8):787-796. PubMed ID: 35553652
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase FBXW11 as a novel inflammatory biomarker is associated with immune infiltration and NF-κB pathway activation in pancreatitis and pancreatic cancer.
Tan P; Cai S; Huang Z; Li M; Liu S; Chen J; Fu W; Zhao L
Cell Signal; 2024 Apr; 116():111033. PubMed ID: 38182068
[TBL] [Abstract][Full Text] [Related]
9. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract][Full Text] [Related]
10. IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer.
Yang J; Liu DJ; Zheng JH; He RZ; Xu DP; Yang MW; Yao HF; Fu XL; Yang JY; Huo YM; Tao LY; Hua R; Sun YW; Kong XM; Jiang SH; Liu W
Cell Oncol (Dordr); 2022 Jun; 45(3):367-379. PubMed ID: 35486320
[TBL] [Abstract][Full Text] [Related]
11. Critical role of NF-κB in pancreatic cancer.
Prabhu L; Mundade R; Korc M; Loehrer PJ; Lu T
Oncotarget; 2014 Nov; 5(22):10969-75. PubMed ID: 25473891
[TBL] [Abstract][Full Text] [Related]
12. Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma.
Wang Y; Wang D; Dai Y; Kong X; Zhu X; Fan Y; Wang Y; Wu H; Jin J; Yao W; Gao J; Wang K; Xu H
Front Oncol; 2021; 11():652283. PubMed ID: 34046348
[TBL] [Abstract][Full Text] [Related]
13. Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer.
Motolani A; Martin M; Wang B; Jiang G; Alipourgivi F; Huang X; Safa A; Liu Y; Lu T
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835439
[TBL] [Abstract][Full Text] [Related]
14. lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer.
Ren X; Chen C; Luo Y; Liu M; Li Y; Zheng S; Ye H; Fu Z; Li M; Li Z; Chen R
Mol Cancer; 2020 Feb; 19(1):35. PubMed ID: 32085715
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer.
Deka K; Li Y
Cells; 2023 Mar; 12(5):. PubMed ID: 36899924
[TBL] [Abstract][Full Text] [Related]
16. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
Liu X; Tang R; Xu J; Tan Z; Liang C; Meng Q; Lei Y; Hua J; Zhang Y; Liu J; Zhang B; Wang W; Yu X; Shi S
Gut; 2023 Nov; 72(12):2329-2343. PubMed ID: 37541772
[TBL] [Abstract][Full Text] [Related]
17. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
18. IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation.
Zhuang Z; Ju HQ; Aguilar M; Gocho T; Li H; Iida T; Lee H; Fan X; Zhou H; Ling J; Li Z; Fu J; Wu M; Li M; Melisi D; Iwakura Y; Xu K; Fleming JB; Chiao PJ
Clin Cancer Res; 2016 Mar; 22(6):1432-44. PubMed ID: 26500238
[TBL] [Abstract][Full Text] [Related]
19. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
Ju HQ; Li H; Tian T; Lu YX; Bai L; Chen LZ; Sheng H; Mo HY; Zeng JB; Deng W; Chiao PJ; Xu RH
J Pineal Res; 2016 Jan; 60(1):27-38. PubMed ID: 26445000
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion
Li K; Zhang Z; Mei Y; Yang Q; Qiao S; Ni C; Yao Y; Li X; Li M; Wei D; Fu W; Guo X; Huang X; Yang H
Theranostics; 2021; 11(7):3196-3212. PubMed ID: 33537082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
